BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31072019)

  • 1. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells.
    Firuzi O; Che PP; El Hassouni B; Buijs M; Coppola S; Löhr M; Funel N; Heuchel R; Carnevale I; Schmidt T; Mantini G; Avan A; Saso L; Peters GJ; Giovannetti E
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31072019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
    Wong CW; Han HW; Tien YW; Hsu SH
    Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
    Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
    Hwang HJ; Oh MS; Lee DW; Kuh HJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells.
    Lenggenhager D; Amrutkar M; Sántha P; Aasrum M; Löhr JM; Gladhaug IP; Verbeke CS
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells.
    Tjomsland V; Aasrum M; Christoffersen T; Gladhaug IP
    Oncotarget; 2017 Sep; 8(42):71672-71684. PubMed ID: 29069737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
    Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
    J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment.
    Giustarini G; Teng G; Pavesi A; Adriani G
    Front Oncol; 2023; 13():1156769. PubMed ID: 37519820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
    Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
    Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.
    Gao Y; Chen MK; Chu YY; Yang L; Yu D; Liu Y; Hung MC
    Am J Cancer Res; 2021; 11(1):236-250. PubMed ID: 33520371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
    Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
    Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
    Avan A; Quint K; Nicolini F; Funel N; Frampton AE; Maftouh M; Pelliccioni S; Schuurhuis GJ; Peters GJ; Giovannetti E
    Curr Pharm Des; 2013; 19(5):940-50. PubMed ID: 22973962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
    Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS
    Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer.
    Sharma R; Malviya R
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188869. PubMed ID: 36842767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudopterosin and
    Xie B; Hänsel J; Mundorf V; Betz J; Reimche I; Erkan M; Büdeyri I; Gesell A; Kerr RG; Ariantari NP; Yu H; Proksch P; Teusch N; Mrsny RJ
    Bioengineering (Basel); 2020 Jun; 7(2):. PubMed ID: 32545910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.